A Review on Flavonoids as a Potential Biomolecule for Inhibiting the Effect of Head and Neck Cancer
Archives of Advances in Biosciences,
Vol. 15 No. 1 (2024),
24 January 2024
,
Page 1-12
https://doi.org/10.22037/aab.v15i1.46931
Abstract
Context: Cancer is one of the most significant, complex, and long-term diseases, characterized by uncontrolled cell multiplication, affecting millions of people around the globe. Developed countries are considered to experience higher incidence and mortality rates due to cancer. Cancer affects various body parts including the liver, breast, lungs, bladder, rectum, prostate, blood, and head and neck. Head and neck cancer is the seventh most prevalent cancer globally, typically arising from tissues of the mouth, larynx, pharynx, trachea, throat, and salivary glands.
Evidence Acquisition: Different factors can cause cancer, such as the use of tobacco, alcohol, genetic alterations, and other environmental factors. Treatment is a challenging part due to the disease’s progression and potential side effects on normal body functions. Current treatments such as chemotherapy have limitations due to their toxic effects on other normal body cells. Therefore, the need for less toxic and more selective treatment arises. Natural phenolic compounds, such as flavonoids derived from plants, fungi, and bacteria, have shown promising potential in the treatment due to a higher therapeutic index and low toxicity level. Flavonoids reduce cancer cell growth, inhibit cancer development enzymes, and regulate apoptosis-related proteins, transcription factors, and pathways. Several studies have shown that their anti-cancer properties have made them effective against head and neck cancer cells.
Results: Plants have been major sources of flavonoids but fungi, especially endophytic fungi are also valuable sources of natural therapeutic agent flavonoids. Extraction of flavonoids from fungi offers a sustainable and environmentally friendly approach, eliminating the need for land, water, and fertilizer. Furthermore, fungi can yield higher amounts of flavonoids than other sources.
Conclusion: Further research in medical applications of flavonoids as biological therapeutic agents could potentially reduce the impact of the disease.
- head and neck cancer
- Flavonoids
- bioactive molecule
- endophytic fungi
How to Cite
References
Zheng PP, Li J, Kros JM. Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights. Medicinal research reviews. 2018 Jan;38(1):325-76. [PMID]
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for cancer treatment: Current perspectives. SAGE open medicine. 2021 Aug;9:20503121211034366. [PMID]
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clinical therapeutics. 2016 Jul 1;38(7):1551-66.[PMID]
Abbas Z, Rehman S. An overview of cancer treatment modalities. Neoplasm. 2018 Sep 19;1:139-57.[LINK]
Organization, W.H., Global health estimates 2020: deaths by cause, age, sex, by country and by region,2000–2019. 2020, WHO Geneva, Switzerland.
Sung, H., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2021. 71(3): p. 209-249.. [PMID]
Omran AR. The epidemiologic transition: a theory of the epidemiology of population change/Abdel R. Omran. [LINK]
Açar Y, Akbulut G. Nutritional epigenetics and phytochemicals in Cancer formation. Journal of the american nutrition association. 2023 Oct 3;42(7):700-5.[PMID]
Eghdami A, Ostovar R, Jafari A, Palmer AJ, Bordbar N, Ravangard R. Economic burden of gastric cancer: a case of Iran. Cancer Control. 2019 Mar 13;26(1):1073274819837185. [PMID]
Zhang PW, Chen L, Huang T, Zhang N, Kong XY, Cai YD. Classifying ten types of major cancers based on reverse phase protein array profiles. PloS one. 2015 Mar 30;10(3):e0123147. [PMID]
Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. Journal of cancer research and practice. 2017 Dec 1;4(4):127-9. [LINK]
Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer—Part 1: Epidemiology, presentation, and prevention. Bmj. 2010 Sep 20;341. [PMID]
Vos, T., et al., Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. 2017. 390(10100): p. 1211-1259. [PMID]
Leemans CR, Snijders PJ, Brakenhoff RH. The molecular landscape of head and neck cancer. Nature Reviews Cancer. 2018 May;18(5):269-82. [PMID]
Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP, Winn DM, Wei Q, Talamini R, Szeszenia-Dabrowska N, Sturgis EM. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. American journal of epidemiology. 2013 Sep 1;178(5):679-90. [PMID]
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Maso LD, Daudt AW, Fabianova E, Wünsch-Filho V, Franceschi S. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Journal of the National Cancer Institute. 2007 May 16;99(10):777-89. [PMID]
Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clinical Cancer Research. 2002 Aug 1;8(8):2553-62. [PMID]
Mehanna H, Beech T, Nicholson T, El‐Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region. Head & neck. 2013 May;35(5):747-55. [PMID]
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus–related and–unrelated oral squamous cell carcinomas in the United States. Journal of clinical oncology. 2008 Feb 1;26(4):612-9.[PMID]
Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P. Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature. Postgraduate medical journal. 2017 Nov;93(1105):704-9. [PMID]
Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and neck cancers. British journal of cancer. 2020 Feb 4;122(3):306-14. [PMID]
Hoxhaj I, Hysaj O, Vukovic V, Leoncini E, Amore R, Pastorino R, Boccia S. Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta‐analysis of the literature. European journal of cancer care. 2020 Sep;29(5):e13255.[PMID]
Poon SL, McPherson JR, Tan P, Teh BT, Rozen SG. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome medicine. 2014 Dec;6:1-4.[PMID]
Shin, M.C., Zhang, J., Min, K.A., Lee, K., Byun, Y., David, A.E., He, H. and Yang, V.C., 2014. Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 102(2), pp.575-587. [PMID]
Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. The Lancet. 2021 Dec 18;398(10318):2289-99. [PMID]
Ciernikova S, Mego M, Chovanec M. Exploring the potential role of the gut microbiome in chemotherapy-induced neurocognitive disorders and cardiovascular toxicity. Cancers. 2021 Feb 13;13(4):782.[PMID]
Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. Journal of Cancer Therapy. 2014 Jul 7;5(8):817-22. [LINK]
Amaral RG, dos Santos SA, Andrade LN, Severino P, Carvalho AA. Natural products as treatment against cancer: a historical and current vision. Clin. Oncol. 2019 Jan;4(5):1562. [LINK]
Majolo F, Delwing LK, Marmitt DJ, Bustamante-Filho IC, Goettert MI. Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery. Phytochemistry Letters. 2019 Jun 1;31:196-207.[LINK]
Mutha RE, Tatiya AU, Surana SJ. Flavonoids as natural phenolic compounds and their role in therapeutics: An overview. Future journal of pharmaceutical sciences. 2021 Dec;7:1-3. [PMID]
Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. The Lancet. 2021 Dec 18;398(10318):2289-99.[PMID]
Gibson C, O’Connor M, White R, Jackson M, Baxi S, Halkett GK. ‘I didn’t even recognise myself’: survivors’ experiences of altered appearance and body image distress during and after treatment for head and neck cancer. Cancers. 2021 Aug 2;13(15):3893 [PMID]
Schwartz DL, Hayes DN. The evolving role of radiotherapy for head and neck cancer. Hematology/Oncology Clinics. 2020 Feb 1;34(1):91-108. [PMID]
Koka K, Verma A, Dwarakanath BS, Papineni RV. Technological advancements in external beam radiation therapy (EBRT): An indispensable tool for cancer treatment. Cancer Management and Research. 2022 Apr 11:1421-9. [PMID]
Brook I. Early side effects of radiation treatment for head and neck cancer. Cancer/radiotherapie. 2021 Jul 1;25(5):507-13.[PMID]
Pendleton KP, Grandis JR. Cisplatin-based chemotherapy options for recurrent and/or metastatic squamous cell cancer of the head and neck. Clinical Medicine Insights: Therapeutics. 2013 Jan;5:CMT-S10409.[PMID]
Ali MM, Aziz TA. Toxic effect of platinum compounds: molecular mechanisms of toxicity. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219). 2021 Oct 30;1:81-8.
Lee L, Gupta M, Sahasranaman S. Immune Checkpoint inhibitors: An introduction to the next‐generation cancer immunotherapy. The journal of clinical pharmacology. 2016 Feb;56(2):157-69. [PMID]
Moreira J, Tobias A, O’Brien MP, Agulnik M. Targeted therapy in head and neck cancer: an update on current clinical developments in epidermal growth factor receptor-targeted therapy and immunotherapies. Drugs. 2017 May;77(8):843-57. [PMID]
Bhole R, Bonde C, Kadam P, Wavwale R. A comprehensive review on photodynamic therapy (PDT) and photothermal therapy (PTT) for cancer treatment. Turkish Journal of Oncology. 2021;36(1).[LINK]
Mali SB. End of life and palliative care decisions in advanced head neck cancer. Oral Oncology Reports. 2024 Sep 1;11:100569.[LINK]
Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. Journal of nutritional science. 2016 Jan;5:e47. [PMID]
Pei, R., X. Liu, and B. Bolling, Flavonoids and gut health. Current Opinion in Biotechnology, 2020. 61: p. 153-159. [PMID]
Drețcanu G, Știrbu I, Leoplold N, Cruceriu D, Danciu C, Stănilă A, Fărcaș A, Borda IM, Iuhas C, Diaconeasa Z. Chemical structure, sources and role of bioactive flavonoids in cancer prevention: a review. Plants. 2022 Apr 20;11(9):1117. [PMID]
Wang JF, Liu SS, Song ZQ, Xu TC, Liu CS, Hou YG, Huang R, Wu SH. Naturally occurring flavonoids and isoflavonoids and their microbial transformation: A review. Molecules. 2020 Nov 3;25(21):5112. [PMID]
Burak M, Imen Y. Flavonoids and their antioxidant properties. Turkiye Klin Tip Bil Derg. 1999;19(1):296-304.
Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food chemistry. 2019 Nov 30;299:125124. [PMID]
Rodríguez-García C, Sánchez-Quesada C, Gaforio JJ. Dietary flavonoids as cancer chemopreventive agents: An updated review of human studies. Antioxidants. 2019 May 18;8(5):137. [PMID]
Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, Abotaleb M, Biringer K, Kudela E, Danko J, Shakibaei M. Flavonoids in cancer metastasis. Cancers. 2020 Jun 8;12(6):1498. [PMID]
Kopustinskiene, D.M., et al., Flavonoids as anticancer agents. Nutrients, 2020. 12(2): p. 457. [PMID]
Ferreira M, Costa D, Sousa Â. Flavonoids-based delivery systems towards cancer therapies. Bioengineering. 2022 May 2;9(5):197. [PMID]
Sahoo BM, Banik BK, Borah P, Jain A. Reactive oxygen species (ROS): key components in cancer therapies. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents). 2022 Jan 1;22(2):215-22.[PMID]
Almatroodi SA, Almatroudi A, Alharbi HO, Khan AA, Rahmani AH. Effects and mechanisms of luteolin, a plant-based flavonoid, in the prevention of cancers via modulation of inflammation and cell signaling molecules. Molecules. 2024 Feb 29;29(5):1093. [PMID]
Ponte LG, Pavan IC, Mancini MC, da Silva LG, Morelli AP, Severino MB, Bezerra RM, Simabuco FM. The hallmarks of flavonoids in cancer. Molecules. 2021 Apr 2;26(7):2029. [PMID]
Costea T, Vlad OC, Miclea LC, Ganea C, Szöllősi J, Mocanu MM. Alleviation of multidrug resistance by flavonoid and non-flavonoid compounds in breast, lung, colorectal and prostate cancer. International journal of molecular sciences. 2020 Jan 8;21(2):401. [PMID]
ur Rehman, M.F., et al., Hesperidin and naringenin, in A centum of valuable plant bioactives. 2021, Elsevier. p. 403-444..
Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, Büsselberg D. Flavonoids in cancer and apoptosis. Cancers. 2018 Dec 28;11(1):28.[PMID]
Hollman PC, Arts IC. Flavonols, flavones and flavanols–nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture. 2000 May 15;80(7):1081-93. [LINK]
KILIÇ EB, MERİÇ ÇS, LÜLE NO, DEVECİ HA. OVERVIEW OF THE EFFECTS OF FLAVONOIDS ON HEALTH. Functional Foods and Nutraceuticals: Bioactive Compounds. 2022 Jun 15:109. [LINK]
de Souza Farias SA, da Costa KS, Martins JB. Analysis of conformational, structural, magnetic, and electronic properties related to antioxidant activity: revisiting flavan, anthocyanidin, flavanone, flavonol, isoflavone, flavone, and flavan-3-ol. ACS omega. 2021 Mar 24;6(13):8908-18. [LINK]
Matthies A, Clavel T, Gütschow M, Engst W, Haller D, Blaut M, Braune A. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Applied and environmental microbiology. 2008 Aug 1;74(15):4847-52. [PMID]
Dziedzic A, Kubina R, Wojtyczka RD, Tanasiewicz M, Varoni EM, Iriti M. Flavonoids induce migration arrest and apoptosis in Detroit 562 oropharynx squamous cell carcinoma cells. Processes. 2021 Feb 27;9(3):426.
Ravishankar D, Rajora AK, Greco F, Osborn HM. Flavonoids as prospective compounds for anti-cancer therapy. The international journal of biochemistry & cell biology. 2013 Dec 1;45(12):2821-31.[PMID]
Raffa D, Maggio B, Raimondi MV, Plescia F, Daidone G. Recent discoveries of anticancer flavonoids. European journal of medicinal chemistry. 2017 Dec 15;142:213-28. [PMID]
Gopal TK, Chamundeeswari D, Sathiya S, Babu CS. In vitro anti-cancer activity of Quercetin and Kaempferol against human epithelial malignant melanoma cells (A375). Int. J. Pharm. Res. Scholars. 2015;4:157-62.
Kubina R, Krzykawski K, Dziedzic A, Kabała-Dzik A. Kaempferol and fisetin-related signaling pathways induce apoptosis in head and neck cancer cells. Cells. 2023 Jun 6;12(12):1568. [PMID]
Ravishankar D, Rajora AK, Greco F, Osborn HM. Flavonoids as prospective compounds for anti-cancer therapy. The international journal of biochemistry & cell biology. 2013 Dec 1;45(12):2821-31.[PMID]
Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, Shaito A, Ghaddar T, Kobeissy F, Eid AH. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomedicine & Pharmacotherapy. 2022 Feb 1;146:112442. [PMID]
Praptiwi P, Fathoni A, Ilyas M. Diversity of endophytic fungi from Vernonia amygdalina, their phenolic and flavonoid contents and bioactivities. Biodiversitas Journal of Biological Diversity. 2020 Jan 9;21(2). [LINK]
Khalil D, El-Zayat SA, El-Sayed MA. Phytochemical screening and antioxidant potential of endophytic fungi isolated from Hibiscus sabdariffa. Journal of Applied Biotechnology Reports. 2020 Jun 22;7(2):116-24.[LINK]
Isticato R, Ricca E. Spore surface display. The bacterial spore: from molecules to systems. 2016 May 1:349-66.[LINK]
GARDENS KR, Kew KR. State of the World’s Plants and Fungi. Londres: Sfumato Foundation. 2020:2020-10.[LINK]
Fathallah N, Raafat MM, Issa MY, Abdel-Aziz MM, Bishr M, Abdelkawy MA, Salama O. Bio-guided fractionation of prenylated benzaldehyde derivatives as potent antimicrobial and antibiofilm from Ammi majus L. fruits-associated Aspergillus amstelodami. Molecules. 2019 Nov 14;24(22):4118. [PMID]
Kumar S, Aharwal RP, Jain R, Sandhu SS. Bioactive molecules of endophytic fungi and their potential in anticancer drug development. Current Pharmacology Reports. 2021 Apr;7:27-41. [LINK]
Ancheeva E, Daletos G, Proksch P. Bioactive secondary metabolites from endophytic fungi. Current medicinal chemistry. 2020 Apr 1;27(11):1836-54. [PMID]
Hölker U, Höfer M, Lenz J. Biotechnological advantages of laboratory-scale solid-state fermentation with fungi. Applied microbiology and biotechnology. 2004 Apr;64:175-86. [LINK]
Sadiran SH. Epigenetic modifiers as tools for the study of secondary metabolites produced by fungi from Malaysia and polar regions (Doctoral dissertation,Universiti Teknologi MARA). [PMID]
Manganyi MC, Ateba CN. Untapped potentials of endophytic fungi: A review of novel bioactive compounds with biological applications. Microorganisms. 2020 Dec 6;8(12):1934. [PMID]
Nzimande B, Kumalo HM, Ndlovu SI, Mkhwanazi NP. Secondary metabolites produced by endophytic fungi, Alternaria alternata, as potential inhibitors of the human immunodeficiency virus. Frontiers in Genetics. 2022 Dec 13;13:1077159. [PMID]
DeMers M. Alternaria alternata as endophyte and pathogen. Microbiology. 2022 Mar 29;168(3):001153. [PMID]
Abdou R, Attia GH, Mojally M, Dawoud M, Rateb ME. Bioguided isolation of alternariol derivatives from Ficus-derived endophyte Alternaria alternata. Indian Journal of Pharmaceutical Education and Research. 2022 Mar 31;56(2):497-502.[LINK]
Chatterjee S, Ghosh R, Mandal NC. Production of bioactive compounds with bactericidal and antioxidant potential by endophytic fungus Alternaria alternata AE1 isolated from Azadirachta indica A. Juss. Plos one. 2019 Apr 4;14(4):e0214744.. [PMID]
- Abstract Viewed: 126 times
- pdf Downloaded: 78 times